FDA Announces 21 Draft Proposals to Increase Transparency

FDA announced the Phase II report on their effort to increase transparency stating:

FDA Announces Transparency Report

FDA Seeks Public Comment on Transparency

On May 19, 2010, the Transparency Task Force released a report containing 21 draft proposals about expanding the disclosure of information by FDA while maintaining confidentiality for trade secrets and individually identifiable patient information. FDA is accepting public comment on the content of the proposals, as well as on which draft proposals should be given priority, on this website until July 20, 2010.

The FDA Report on the 21 Draft Proposals is available in PDF format.

The Blog will be reading the report carefully and urges you to do so as well.

UPDATE: In other news of interest FDA’s Principal Deputy Commissioner, Dr. Joshua M. Sharfstein, testified to Congress about the recall of adulterated Tylenol and other pediatric medicines. The New York Times reported that FDA is considering additional penalties including the possibility of criminal prosecution.


GxP Perspectives LinkedIn Group

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: